Lighthouse Institute, Chestnut Health Systems
Normal, Illinois, 61761, United States
NCT Number: NCT01016704
The specific aims of the proposed study are to evaluate the effectiveness and cost-effectiveness of providing monetary incentives to therapists as a method to improve implementation of evidence-based treatments.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Normal, Illinois, 61761, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants assigned to the experimental condition are reinforced via monetary incentives for demonstrating superior delivery of an evidence treatment to clients
Time frame: 14 weeks post intake
Based on a review of recordings of actual client sessions is an indicator of whether or not clients received 10 or more of 12 specified treatment procedures within no less than seven treatment sessions.
Time frame: Monthly
Based on review of a randomly selected session recording is an indicator of whether or not participants delivered at least one treatment procedure at or above the level of competence required as part of the certification process.
Time frame: 6 months post-intake
Based on client self report is the percentage of days during the past 90 days that clients reported not using any alcohol or other drugs.
Time frame: First six months of study
The cost per unit of Target A-CRA, A-CRA Competene, and Percentage of Days Abstient in the experimental condition relative to the control condition.
Chestnut Health Systems
Other
Acronym: RTP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04873401
COVID-19, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05378399
Adherence, Medication, Adherence, Treatment
Boston, Massachusetts, United States
View Trial DetailsNCT05286879
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06008990
Buprenorphine Dependence, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial Details